Please login to the form below

Not currently logged in
Email:
Password:

Teva CFO retires as Q3 FY07 profits decline

Teva Pharmaceutical Industries revealed a 13 per cent drop in Q3 FY07 profits and also announced the retirement of its CFO, Dan Suesskind.

Teva Pharmaceutical Industries revealed a 13 per cent drop in Q3 FY07 profits and also announced the retirement of its CFO, Dan Suesskind.

Teva posted a decline in Q3 net income to USD 525m (USD 0.64 per share) from USD 606m (USD 0.74 per share) in Q3 FY06. The companyπs quarterly sales were USD 2.4bn in Q3, up from USD 2.3bn in the same quarter a year earlier.

Suesskind will retire in mid-2008 after spending 31 years with the pharmaceutical firm. He will be replaced by Eyal Desheh, the CFO of Israeli Check Point Software Technologies.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics